The bank’s ‘Today, Tomorrow, Forever’ framework helps families organise and navigate their wealth across three interconnected ...

MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches across all sgRNA positions with near-zero ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by ...

Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely enables them to hide from immune attack.

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Audioengine makes some of the most popular desktop speakers around … and it seems to have found a successful formula of upgrading them to meet modern standards. Earlier this year, the Texas-based ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Abstract: Automated Radiology report generation (RRG) aims at producing detailed descriptions of medical images, reducing radiologists’ workload and improving access to high-quality diagnostic ...

Cell free RNA diagnostics market is projected to reach US$ 204.5 Mn by 2035, expanding at a CAGR of 14.5% from 2025 to 2035 ...

Genetron Holdings Ltd, a leading precision oncology platform in China also known as Genetron Health, announced on Tuesday ...

Some younger patients with B-cell acute lymphoblastic leukemia may be able to avoid total body irradiation conditioning prior ...